| You are here: Home: BCU Surgeons Vol.2 Issue 4: CME
Information
Breast Cancer Update for
Surgeons: A CME Audio Series and Activity
STATEMENT OF NEED/TARGET
AUDIENCE
Breast cancer is one of the most rapidly
evolving fields in oncology. Published results from a plethora
of ongoing clinical trials lead to the continuous emergence of
new therapeutic techniques, agents and changes in the indications
for existing treatments. In order to offer optimal patient care — including
the option of clinical trial participation — the practicing breast
surgeon must be well-informed of these advances. To bridge the
gap between research and patient care, Breast
Cancer Update for Surgeons utilizes
one-on-one discussions with leading breast cancer investigators.
By providing access to the latest research developments and expert
perspectives, this CME program assists breast surgeons in the
formulation of up-to-date clinical management strategies.
GLOBAL LEARNING OBJECTIVES
Upon completion of this activity, participants
should be able to:
- Critically evaluate the clinical implications
of emerging clinical trial data in the prevention and treatment
of noninvasive (DCIS) and invasive breast cancer.
- Counsel postmenopausal patients with
estrogen receptor-positive tumors about the risks and benefits
of aromatase inhibitors in the adjuvant and neoadjuvant setting.
- Describe the current guidelines for,
and ongoing clinical trials of, local and regional therapy
for noninvasive and invasive breast cancer.
Issue 4, 2003 of Breast
Cancer Update for Surgeons consists
of discussions with five research leaders on a variety of important
topics including use of bisphosphonates, adjuvant endocrine therapy,
management of hot flashes, sentinel lymph node biopsy and partial
breast irradiation.
SPECIFIC LEARNING OBJECTIVES
FOR ISSUE 4
Upon completion of this activity, participants
should be able to:
- Consider the absolute and relative contraindications
to sentinel lymph node biopsy when deciding on optimal surgical
management of the axilla.
- Evaluate the major cooperative group
trials of sentinel lymph node biopsy in order to counsel patients
regarding participation.
- Describe the ongoing clinical trials
of systemic therapy for DCIS.
- Discuss the results of the ATAC trial
and the implications of treating postmenopausal women with
ER-positive breast cancer.
- Counsel breast cancer patients and survivors
about nonestrogenic treatment alternatives for women with severe
hot flashes.
- Consider the potential benefits and limitations
of partial breast irradiation compared to whole breast radiation
therapy.
ACCREDITATION STATEMENT
NL Communications Inc is accredited by the
Accreditation Council for Continuing Medical Education to provide
continuing medical education for physicians.
CREDIT DESIGNATION STATEMENT
NL Communications Inc designates this educational
activity for a maximum of 2.75 category 1 credits towards the
AMA Physician's Recognition Award. Each physician should claim
only those credits that he/she actually spent on the activity.
|
